Strategic merger Landrace Bioscience merged with Care Beyond Diagnosis to form 11Three, signaling a broader capabilities platform and potential cross-selling of solubilized delivery solutions to Care Beyond Diagnosis’s network.

SENDS portfolio Recent emphasis on Solubilized Enhanced Drug Delivery System (SENDS) suggests opportunities to position Landrace as a partner for beverage, nutraceutical, cosmetic, and pharmaceutical manufacturers seeking improved solubility and bioavailability of cannabinoid ingredients.

Partnered legacy Historically collaborated with Abacus Health Products for hemp extract supply, indicating established B2B routes with OTC topical brands; potential to re-engage or expand into CBDMEDIC and CBDCLINIC-like lines.

Industry fit Operating in wellness and fitness services with a hemp extract specialty and mid-market employee base, presenting a value proposition to mid-tier wellness brands looking for flexible R&D formulation, customization, and scalable manufacturing.

Growth signal Revenue range of one to ten million and recent product launch cadence reflect a growth-ready profile suitable for introductions to strategic investors, contract manufacturers, and distribution partners seeking innovative cannabinoid delivery platforms.